Organon declares $0.02 quarterly dividend for shareholders
Organon declared a $0.02 quarterly dividend per share of common stock. The payment will be made on September 10, 2026, to shareholders of record as of August 14, 2026. This distribution supports investor returns for the global healthcare firm.
*this image is generated using AI for illustrative purposes only.
Organon, a global healthcare company focused on women’s health and general medicines, has declared a quarterly dividend of $0.02 for each issued and outstanding share of its common stock. The Board of Directors announced the distribution, which provides direct cash returns to investors holding the stock as of the record date. This declaration underscores the company’s commitment to shareholder value amidst its mission to deliver impactful medicines across more than 140 markets.
The dividend is payable on September 10, 2026. To qualify for this payment, stockholders must hold their shares at the close of business on August 14, 2026. Investors should ensure their holdings are registered correctly before the record date to receive the distribution.
Dividend Details
The following table outlines the key dates and amounts associated with this quarterly distribution:
| Detail | Value |
|---|---|
| Dividend per share | $0.02 |
| Record date | August 14, 2026 |
| Payment date | September 10, 2026 |
Company Overview
Headquartered in Jersey City, New Jersey, Organon operates with a portfolio of over 70 products. Its focus remains on addressing health needs that uniquely, disproportionately, or differently affect women, while also expanding access to essential treatments including biosimilars. The company continues to advance access, affordability, and innovation in healthcare globally.
How does Organon's $0.02 quarterly dividend compare to the average payout ratios of other women's health-focused pharmaceutical companies?
What impact might this dividend declaration have on Organon's stock price volatility in the weeks leading up to the August 14, 2026 record date?
Will Organon maintain this dividend rate for future quarters, or does it signal a shift in capital allocation strategy toward R&D or debt reduction?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
